the growing role of anti-pd1 inhibitors in the frontline treatment of hl
Published 1 year ago • 81 plays • Length 2:32Download video MP4
Download video MP3
Similar videos
-
2:29
the importance of pd1 blockade in the treatment of classical hl
-
1:14
pd-l1 inhibitors in r/r hodgkin lymphoma
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
3:51
novel developments in relapsed/refractory hl: checkpoint inhibitors, bispecifics and car-t cells
-
1:36
the changing role of chemotherapy in lymphoma and the value of novel immunotherapies
-
6:24
tnb-486: interim results of a cd19/cd3 t-cell engager in r/r follicular lymphoma
-
1:02:49
pd-l1/pd-1 cancer immunotherapy and new targets - gordon freeman, phd
-
3:03
how bad is lymphoma cancer?
-
1:29
pd-1 blockade in hodgkin lymphoma: moving up the ranks
-
2:55
post-transplant pd1 blockade plus autologous lymphocytes in r/r hl
-
2:04
the importance of individualizing treatment approaches in hl to improve patient outcomes
-
1:12
the use of end-of-treatment pet in early-stage hodgkin lymphoma
-
2:29
findings from the hd21 trial: safety profile of the brecadd regimen in hl
-
2:04
imc-001: preliminary results of novel pd-l1 inhibitor for r/r extranodal nk/t cell lymphoma
-
1:15
tackling pd1i resistance in hodgkin lymphoma
-
1:00
the role of non-covalent btk inhibitors in the treatment of non-hodgkin lymphoma
-
1:28
investigating ab1 as a tool to upregulate fetal hemoglobin in scd: preclinical and clinical findings
-
2:03
novel therapeutic agents in the treatment of hodgkin and non-hodgkin lymphoma
-
1:11
distinkt trial analysis: efficacy and safety of imc-001 for r/r enktl
-
2:11
allohsct in hodgkin lymphoma post pd-1 inhibitors
-
1:19
the role of chemotherapy in hodgkin lymphoma
-
6:16
overview of novel restore and target treatment approach to classical hodgkin lymphoma